山东大学学报 (医学版) ›› 2024, Vol. 62 ›› Issue (12): 96-101.doi: 10.6040/j.issn.1671-7554.0.2024.1010
• 临床医学 • 上一篇
牛雅文,李凤娇
NIU Yawen, LI Fengjiao
摘要: 目的 研究蛋白酶激活受体-2(protease activated receptor-2, PAR-2)在烟曲霉菌感染的人永生化角膜上皮细胞(human corneal epithelial cells, HCECs)中的表达,探讨PAR-2对炎症因子水平的影响及其作用机制。 方法 烟曲霉菌灭活菌丝刺激HCECs,制备体外烟曲霉菌感染模型,观察烟曲霉菌灭活菌丝对PAR-2表达水平的影响,并观察PAR-2 拮抗剂(FSLLRY-NH2)预处理HCECs后,炎症因子IL-1β和TNF-α,以及信号通路分子p-p38的水平变化。 结果 烟曲霉菌刺激HCECs后PAR-2表达水平升高。烟曲霉菌刺激引起IL-1β、TNF-α以及p-p38的表达升高,这一升高被PAR-2拮抗剂明显抑制。 结论 烟曲霉菌刺激增加PAR-2的表达,并通过PAR-2/p38 MAPK信号通路诱导炎症因子的产生。
中图分类号:
[1] 庞金鼎, 韦振宇, 曹凯, 等. 不同抗真菌药物治疗真菌性角膜炎有效性和安全性的网状Meta分析[J]. 中华实验眼科杂志, 2024, 42(7): 629-637. PANG Jinding, WEI Zhenyu, CAO Kai, et al. A network meta-analysis of the efficacy and safety of different antifungal drugs for fungal keratitis[J]. Chinese Journal of Experimental Ophthalmology, 2024, 42(7): 629-637. [2] 戴晨阳,郭慧. 白细胞介素-36在真菌性角膜炎中的免疫作用及机制[J]. 山东大学学报(医学版), 2024, 62(8): 67-73. DAI Chenyang, GUO Hui. Progress in the immune effect and mechanism of IL-36 in fungal keratitis[J]. Journal of Shandong University(Health Sciences), 2024, 62(8): 67-73. [3] Brown L, Leck AK, Gichangi M, et al. The global incidence and diagnosis of fungal keratitis[J]. Lancet Infect Dis, 2021, 21(3): 49-57. [4] 周晓丹, 杨玉倩, 徐强崧. 真菌性角膜炎的致病菌菌属和转归及其影响因素分析[J]. 国际眼科杂志, 2022, 22(11): 1892-1895. ZHOU Xiaodan, YANG Yuqian, XU Qiangsong. Analysis of pathogenic bacterial Genera and outcome of fungal keratitis and their influencing factors[J]. International Eye Science, 2022, 22(11): 1892-1895. [5] Mahmoudi S, Masoomi A, Ahmadikia K, et al. Fungal keratitis: an overview of clinical and laboratory aspects[J]. Mycoses, 2018, 61(12): 916-930. [6] Mills B, Radhakrishnan N, Karthikeyan Rajapandian SG, et al. The role of fungi in fungal keratitis[J]. Exp Eye Res, 2021, 202: 108372. doi:10.1016/j.exer.2020.108372. [7] Heinekamp T, Schmidt H, Lapp K, et al. Interference of Aspergillus fumigatus with the immune response[J]. Semin Immunopathol, 2015, 37(2): 141-152. [8] Shpacovitch V, Feld M, Bunnett NW, et al. Protease-activated receptors: novel PARtners in innate immunity[J].Trends Immunol, 2007, 28(12): 541-550. [9] Moretti S, Bellocchio S, Bonifazi P, et al. The contribution of PARs to inflammation and immunity to fungi[J]. Mucosal Immunol, 2008, 1(2): 156-168. [10] Rayees S, Joshi JC, Joshi B, et al. Protease-activated receptor 2 promotes clearance of Pseudomonas aeruginosa infection by inducing cAMP-Rac1 signaling in alveolar macrophages[J]. Front Pharmacol, 2022, 13: 874197. doi:10.3389/fphar.2022.874197. [11] Lee SE, Kim JM, Jeong SK, et al. Protease-activated receptor-2 mediates the expression of inflammatory cytokines, antimicrobial peptides, and matrix metalloproteinases in keratinocytes in response to Propionibacterium acnes[J]. Arch Dermatol Res, 2010, 302(10): 745-756. [12] Niu YW, Zhao GQ, Li C, et al. Aspergillus fumigatus increased PAR-2 expression and elevated proinflammatory cytokines expression through the pathway of PAR-2/ERK1/2 in Cornea[J]. Invest Ophthalmol Vis Sci, 2018, 59(1): 166-175. [13] Rivas CM, Schiff HV, Moutal A, et al. Alternaria alternata-induced airway epithelial signaling and inflammatory responses via protease-activated receptor-2 expression[J]. Biochem Biophys Res Commun, 2022, 591: 13-19. doi:10.1016/j.bbrc.2021.12.090. [14] Tripathi T, Abdi M, Alizadeh H. Protease-activated receptor 2(PAR2)is upregulated by Acanthamoeba plasminogen activator(aPA)and induces proinflammatory cytokine in human corneal epithelial cells[J]. Invest Ophthalmol Vis Sci, 2014, 55(6): 3912-3921. [15] Wilson SE, Torricelli AAM, Marino GK. Corneal epithelial basement membrane: structure, function and regeneration[J]. Exp Eye Res, 2020, 194: 108002. doi:10.1016/j.exer.2020.108002. [16] Chi MH, Gu LW, Zhang LN, et al. Pentoxifylline treats Aspergillus fumigatus keratitis by reducing fungal burden and suppressing corneal inflammation[J]. Eur J Pharmacol, 2023, 945: 175607. doi:10.1016/j.ejphar.2023.175607. [17] Wang Ms J, Kang Ms X, Huang Ms ZQ, et al. Protease-activated receptor-2 decreased zonula occlidens-1 and claudin-1 expression and induced epithelial barrier dysfunction in allergic rhinitis[J]. Am J Rhinol Allergy, 2021, 35(1): 26-35. [18] Matos NLA, Oliveira Lima OSC, DA Silva JF, et al. Blockade of protease-activated receptor 2 attenuates allergenmediated acute lung inflammation and leukocyte recruitment in mice[J]. J Biosci, 2022, 47: 2. [19] Silva IS, Almeida AD, Lima Filho ACM, et al. Platelet-activating factor and protease-activated receptor 2 cooperate to promote neutrophil recruitment and lung inflammation through nuclear factor-kappa B transactivation[J]. Sci Rep, 2023, 13(1): 21637. doi:10.1038/s41598-023-48365-1. [20] de Almeida AD, Silva IS, Fernandes-Braga W, et al. A role for mast cells and mast cell tryptase in driving neutrophil recruitment in LPS-induced lung inflammation via protease-activated receptor 2 in mice[J]. Inflamm Res, 2020, 69(10): 1059-1070. [21] Chao HH, Chen PY, Hao WR, et al. Lipopolysaccharide pretreatment increases protease-activated receptor-2 expression and monocyte chemoattractant protein-1 secretion in vascular endothelial cells[J]. J Biomed Sci, 2017, 24(1): 85. doi:10.1186/s12929-017-0393-1. [22] Cuadrado A, Nebreda AR. Mechanisms and functions of p38 MAPK signalling[J]. Biochem J, 2010, 429(3): 403-417. [23] Wang JH, Liu YJ, Guo YS, et al. Function and inhibition of P38 MAP kinase signaling: targeting multiple inflammation diseases[J]. Biochem Pharmacol, 2024, 220: 115973. doi:10.1016/j.bcp.2023.115973. [24] Sarg NH, Zaher DM, Abu Jayab NN, et al. The interplay of p38 MAPK signaling and mitochondrial metabolism, a dynamic target in cancer and pathological contexts[J]. Biochem Pharmacol, 2024, 225: 116307. doi:10.1016/j.bcp.2024.116307. [25] Saleem S. Targeting MAPK signaling: a promising approach for treating inflammatory lung disease[J]. Pathol Res Pract, 2024, 254: 155122. doi:10.1016/j.prp.2024.155122. [26] Niu YW, Lin J, Li C, et al. Galectin-3 plays an important pro-inflammatory role in A. fumigatus keratitis by recruiting neutrophils and activating p38 in neutrophils[J]. Int Immunopharmacol, 2021, 97: 107706. doi:10.1016/j.intimp.2021.107706. [27] Wang Q, Zhao GQ, Lin J, et al. Role of the mannose receptor during Aspergillus fumigatus infection and interaction with dectin-1 in corneal epithelial cells[J]. Cornea, 2016, 35(2): 267-273. [28] Diao WL, Yin M, Qi YH, et al. Resveratrol has neuroprotective effects and plays an anti-inflammatory role through Dectin-1/p38 pathway in Aspergillus fumigatus keratitis[J]. Cytokine, 2024, 179: 156626. doi:10.1016/j.cyto.2024.156626. [29] Jia YY, Li C, Yin M, et al. Kaempferol ameliorate the prognosis of Aspergillus fumigatus keratitis by reducing fungal load and inhibiting the Dectin-1 and p38 MAPK pathway[J]. Exp Eye Res, 2022, 216: 108960. doi:10.1016/j.exer.2022.108960. |
[1] | 潘静,于潇,刘金星,刘鹏飞. 始基卵泡激活调控的研究进展[J]. 山东大学学报 (医学版), 2024, 62(8): 74-92. |
[2] | 闫小龙,秦英,邵将,陈东峰,管东辉,赵灿斌. 姜黄素通过Wnt/β-catenin信号通路调控骨形成的机制[J]. 山东大学学报 (医学版), 2024, 62(10): 76-86. |
[3] | 秦金金,曹辰媛,邢杰杰,安燕,黄煜湘. 子痫前期相关Siglec-6核心基因的预测及生物信息学分析[J]. 山东大学学报 (医学版), 2024, 62(1): 31-37. |
[4] | 刘金波,刘凯文,向崇鑫,程雷. 西红花苷对椎间盘退变的保护作用[J]. 山东大学学报 (医学版), 2023, 61(9): 84-93. |
[5] | 张嘉颖,宿荣允,王英惠,王洪刚,柳刚. ACE2基因通过调控Nrf2/HO-1通路改善肾缺血再灌注损伤[J]. 山东大学学报 (医学版), 2023, 61(4): 1-9. |
[6] | 芦兴晨,强晔,刘昕宇,左丹,姜子晗,张玉超,刘元涛,马小莉. NR4A1对毒胡萝卜素诱导C2C12肌管细胞糖代谢功能障碍的影响[J]. 山东大学学报 (医学版), 2023, 61(11): 38-47. |
[7] | 邹品衡,陈添果,胡康,李伟才. 过表达miR-27a对急性脑梗死大鼠海马神经元损伤的影响及其机制[J]. 山东大学学报 (医学版), 2022, 60(9): 59-66. |
[8] | 张凤,吴哲,徐俊,刘玉兰. 6例非酒精性脂肪性肝病小鼠肠道B细胞的变化[J]. 山东大学学报 (医学版), 2022, 60(9): 67-73. |
[9] | 张秉芬,周胜红,王哲. 延龄草皂苷通过抑制TGF-β/Smad3与Wnt/β-catenin信号通路改善大鼠肺纤维化[J]. 山东大学学报 (医学版), 2022, 60(8): 23-29. |
[10] | 相宇娇,刘强,刘璐,石艳. 原发免疫性血小板减少症树突状细胞异常免疫反应机制[J]. 山东大学学报 (医学版), 2022, 60(7): 89-97. |
[11] | 邬雨洁,张明泉,纪永利,赵璐,王越,陈沙沙. 寒痉汤及其拆方对寒凝证高血压大鼠血清炎症因子、血管内皮功能及纤维化的影响[J]. 山东大学学报 (医学版), 2022, 60(6): 10-18. |
[12] | 张秀芳,李沛铮,张博涵,孙丛丛,刘艺鸣. 生长分化因子15在LPS诱导的帕金森病模型中的保护作用及机制[J]. 山东大学学报 (医学版), 2022, 60(5): 1-7. |
[13] | 虎娜,孙苗,邢莎莎,许丹霞,海小明,马玲,杨丽,勉昱琛,何瑞,陈冬梅,马会明. 月见草油抵抗多囊卵巢综合征大鼠卵巢氧化应激[J]. 山东大学学报 (医学版), 2022, 60(5): 22-30. |
[14] | 申晓畅,孙一卿,颜磊,赵兴波. 芳基烃受体核转位因子样蛋白2在子宫内膜癌中的表达[J]. 山东大学学报 (医学版), 2022, 60(5): 74-80. |
[15] | 孙继业,王紫欧,孙晓伟,李洪涛. 中药熏蒸联合体外冲击波对72例髋关节撞击综合征临床疗效、血清炎症因子水平的影响[J]. 山东大学学报 (医学版), 2022, 60(4): 76-81. |
|